PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.38%
Revenue growth above 1.5x STERV.HE's 2.42%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
138.16%
Gross profit growth above 1.5x STERV.HE's 35.57%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
17.40%
EBIT growth 50-75% of STERV.HE's 33.10%. Martin Whitman would suspect suboptimal resource allocation.
17.40%
Operating income growth at 50-75% of STERV.HE's 33.10%. Martin Whitman would doubt the firm’s ability to compete efficiently.
38.46%
Net income growth above 1.5x STERV.HE's 25.27%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
50.60%
EPS growth above 1.5x STERV.HE's 16.67%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
50.60%
Diluted EPS growth above 1.5x STERV.HE's 16.67%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-8.06%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-53.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-82.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-30.86%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.50%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
454.41%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-18.73%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
243.74%
3Y OCF/share CAGR above 1.5x STERV.HE's 23.88%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
128.82%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
302.67%
5Y net income/share CAGR above 1.5x STERV.HE's 56.16%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
47.12%
3Y net income/share CAGR above 1.5x STERV.HE's 15.15%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
26.22%
5Y equity/share CAGR above 1.5x STERV.HE's 0.12%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
27.90%
3Y equity/share CAGR above 1.5x STERV.HE's 11.88%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.34%
AR growth well above STERV.HE's 3.84%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.60%
Inventory growth well above STERV.HE's 15.59%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.29%
Asset growth at 50-75% of STERV.HE's 0.47%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
6.68%
BV/share growth above 1.5x STERV.HE's 1.71%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
5.88%
We have some new debt while STERV.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.58%
We cut SG&A while STERV.HE invests at 12.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.